Matsuya R&D
7317.TTSE GROWTH
Filed as Matsuya R&D Co., Ltd (2022-06–2026-06)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥9.8bn | ¥9.6bn | ¥8.4bn | ¥7.2bn | ¥5.6bn | ¥7.3bn |
| Operating income | ¥2.1bn | ¥2.0bn | ¥1.3bn | ¥612m | ¥355m | ¥838m |
| Ordinary income | ¥2.2bn | ¥2.1bn | ¥1.3bn | ¥675m | ¥409m | ¥831m |
| Net income (owners) | ¥1.5bn | ¥1.6bn | ¥953m | ¥426m | ¥165m | ¥569m |
| Total assets | ¥12.5bn | ¥10.9bn | ¥9.9bn | ¥8.7bn | ¥6.9bn | ¥6.2bn |
| Net assets / equity | ¥8.1bn | ¥6.9bn | ¥5.2bn | ¥3.8bn | ¥3.2bn | ¥2.8bn |
| Operating cash flow | ¥1.3bn | ¥2.6bn | ¥528m | ¥915m | ¥140m | ¥656m |
| EPS (basic) | ¥72.5 | ¥73.38 | ¥45.03 | ¥20.17r | ¥7.85r | ¥27.46r |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 74 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 74 figures · EDINET |
9 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Medical Healthcare | ¥6.8bn | ¥2.1bn |
| Safety System | ¥2.9bn | ¥397m |
| Other segments | ¥102m | −¥35m |
| Adjustments & eliminations | — | −¥356m |
| Total | ¥9.8bn | ¥2.5bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.